Evidence map›Paper›PMID 29543319›Full record

ArticleCancer2018

Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Sarah Sloot, Yian A Chen, Xiuhua Zhao, Jamie L Weber, Jacob J Benedict, James J Mulé, Keiran S Smalley, Jeffrey S Weber, Jonathan S Zager, Peter A Forsyth and 2 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sarah SlootDepartment of General Surgery, Groningen University Medical Center, Groningen, The Netherlands.
Yian A ChenDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.
Xiuhua ZhaoDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.
Jamie L WeberMorsani College of Medicine, University of South Florida, Tampa, Florida.
Jacob J BenedictMorsani College of Medicine, University of South Florida, Tampa, Florida.
James J MuléDepartment of Immunology, Moffitt Cancer Center, Tampa, Florida.
Keiran S SmalleyDepartment of Cutaneous Oncology; Department of Tumor Biology, Moffitt Cancer Center, Tampa, Florida.
Jeffrey S WeberLaura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
Jonathan S ZagerDepartment of Cutaneous Oncology, Moffitt Cancer Center; Department of Oncologic Sciences; Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Peter A ForsythDepartment of Neurooncology, Moffitt Cancer Center, Tampa, Florida; Department of Neurooncology, Southern Alberta Cancer Research Institute, Calgary, Alberta, Canada.
Vernon K SondakDepartment of Cutaneous Oncology, Moffitt Cancer Center; Department of Oncologic Sciences; Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Geoffrey T GibneyGeorgetown Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsMelanomaHumansNeoplasm StagingProto-Oncogene Proteins B-rafUnited StatesBRAF protein, humanProto-Oncogene Proteins B-raf

Identifiers

PMID29543319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.